Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: Potential for clinical application

Blood

Volumn 99, Issue 9, 2002, Pages 3319-3325

  Von Bergwelt Baildon, Michael S ^a,b,c   Vonderheide, Robert H ^a,b,c   Maecker, Britta ^a,b,c   Hirano, Naoto ^a,b,c   Anderson, Karen S ^a,b,c   Butler, Marcus O ^a,b,c   Xia, Zhinan ^a,b,c   Zeng, Wan Y ^a,b,c   Wucherpfennig, Kai W ^a,b,c   Nadler, Lee M ^a,b,c   Schultze, Joachim L ^a,b,c,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GUANOSINE PHOSPHATE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MEMORY CELL; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0036565877     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3319     Document Type: Article

References (60)

1. The dendritic cell system and its role in immunogenicity
2. Dendritic cells and the control of immunity
3. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
4. Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells
5. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro
6. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
7. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
8. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
9. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
10. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
11. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells
12. Induction of primary carcino-embryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
13. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies
14. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
15. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
16. Dendritic cells can present antigen in vivo in a toferogenic or immunogenic fashion
17. Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction
18. Dendritic cells and immune-based therapies
19. Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation
20. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
21. Human gene therapy
22. CD40 activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy
23. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
24. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
25. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
26. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
27. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
28. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154)
29. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity
30. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
31. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
32. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein
33. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
34. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
35. Cellular peptide composition governed by major histo-compatibility complex class I molecules
36. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immuno-dominant peptide analogues
37. Phenotypic analysis of antigen-specific T lymphocytes
38. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40
39. New perspectives of CD28-B7-mediated T cell costimulation
40. Accessory molecule and costimulation requirements for CD4 T cell response
41. Cellular responses to interferon-gamma
42. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
43. Adoptive cellular immunotherapy for EBV lymphoproliferative disease
44. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines
45. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells
46. Dendritic cells in cancer immunotherapy
47. Detection of peptide-MHC class II complexes on the surface of intact cells
48. A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins
49. A europium fluoroimmunoassay for measuring peptide binding to MHC class I molecules
50. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses
51. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance
52. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production
53. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: Implications for immune augmentation cancer therapy and autoimmunity
54. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro
55. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses
56. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
57. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand
58. Immune surveillance against a solid tumor fails because of immunological ignorance
59. Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice